中文 | English
Return
Total: 486 , 1/49
Show Home Prev Next End page: GO
Author:(Zi Wei ZHANG)

3.Preparation of Platycodin-D for Reference Substance

Wei LI ; Jing ZHANG ; Huiping LI ; Zi WANG ; Yinan ZHENG

Traditional Chinese Drug Research & Clinical Pharmacology 1993;0(01):-

4.The latest research progress of torpor occurrence mechanism

Zi-yu ZHU ; Jian-wei JIANG ; Jian-jun ZHANG

Acta Pharmaceutica Sinica 2021;56(6):1532-1536

5.Nerve Stem Cells Orientation Differentiation in Neonatal Rat Hippocampus Induced by Brain-Derived Neurotrophic Factor in Vitro

jun-feng, YU ; zi-jin, YANG ; wei-hong, ZHANG

Journal of Applied Clinical Pediatrics 2006;0(14):-

6.Research progress of the role of PPARγ in autoimmune diseases

Yan YANG ; Yu ZHOU ; Ya-zi WEI ; Tian-tai ZHANG

Acta Pharmaceutica Sinica 2022;57(10):3124-3132

7.Problematic issues in clinical trials of mesenchymal stem cells and unraveling strategies.

Wei-Wei ZHANG ; Zi-Kuan GUO

Journal of Experimental Hematology 2007;15(4):901-904

8.Clinical analysis of ligustrazine in the treatment of chronic renal failure

wei Zi CHEN ; Wei ZHANG

Chinese Journal of Biochemical Pharmaceutics 2017;37(10):223-224

9.Clinical effect of Yisui decoction plus western medicine in treating multiple system atrophy.

Pei-Ran ZHANG ; Gai-Hui GUO ; Wei-Hong GU ; Zi-Yi ZHANG ; Kang WANG ; Miao JIN

China Journal of Chinese Materia Medica 2014;39(15):2968-2971

10.Effect of hemodialysis on pharmacokinetics of sparfIoxacin in the patients with chronic renal failure

Zhu LIANG ; Rong-Zi SHAO ; Ying-Wei ZHANG ; Ei-Ping ZHANG ; Chen YUAN ;

Chinese Journal of Clinical Pharmacology and Therapeutics 1999;0(04):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 486 , 1/49 Show Home Prev Next End page: GO